Contact Us

No Form
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

   * Please describe your case:

Date of Incident : 

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Canada Pulls Anti-Depressant Off Shelves

Nov 24, 2003 | Canadian Press

a href="http://www.yourlawyer.com/practice/overview.htm?topic=Serzone">More information on Serzone side effects

An anti-depressant drug called nefazodone is being pulled from the market because it has been linked to serious liver damage, Health Canada says.

"This risk, while very remote, poses a greater risk than other similar anti-depressants currently available in Canada," the federal department said.

Nefazodone is a prescription-only product approved in 1994 and sold under the trade name Serzone by Bristol-Myers Squibb Canada Inc.

It is also sold under the generic names Lin-Nefazodone, Apo-Nefazodone, Nefazodone, Dom-Nefazodone, Novo-Nefazodone-5HT2, PMS-Nefazodone and Gen-Nefazodone.

Health Canada says it is aware of 38 Canadian cases of liver-related adverse effects, including one death, believed to be associated with the drug from 1994 until the end of last year.

Bristol-Myers Squibb and Linson Pharma agreed to have their products withdrawn by Thursday.


Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo